Altimmune to Present at the 2021 Jefferies Virtual Healthcare Conference

May 27, 2021 at 7:00 AM EDT

GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.

Details on the Jefferies fireside chat presentation are as follows:

  Title:   2021 Jefferies Virtual Healthcare Conference
  Presenters:   Vipin Garg, Ph.D., Chief Executive Officer
      Scot Roberts, Ph.D., Chief Scientific Officer
      Scott Harris, M.D., Chief Medical Officer
  Date/Time:   Wednesday, June 2, 2021 at 11:30 am ET

A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit

Investor & Media Contacts:    
Will Brown   Stacey Jurchison
Chief Financial Officer    Sr. Dir, Investor Relations
Phone: 240-654-1450   Phone : 410-474-8200


Primary Logo

Source: Altimmune, Inc.


Investor Contact

Will Brown
Chief Financial Officer



Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail